Go Pro
NASDAQ:ASTC

Astrotech Q3 2026 Earnings Report

Astrotech logo
$7.16 +0.39 (+5.68%)
As of 12:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Astrotech EPS Results

Actual EPS
-$2.25
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Astrotech Revenue Results

Actual Revenue
$0.34 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Astrotech Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Astrotech Earnings Headlines

Astrotech (NASDAQ:ASTC) Raised to Sell at Wall Street Zen
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.tc pixel
ASTROTECH APPOINTS MATT KREPS TO BOARD OF DIRECTORS
See More Astrotech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Astrotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Astrotech and other key companies, straight to your email.

About Astrotech

Astrotech (NASDAQ:ASTC) Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms. A key milestone was the spin-out of 908 Devices in 2020, a subsidiary that developed portable mass spectrometers for field detection of chemicals and bio-agents. Building on that foundation, Astrotech continues to pursue point-of-care screening technologies for environmental monitoring, food safety and clinical diagnostics.

Through Astrotech Solar and other affiliates, the company is also active in renewable energy commercialization. This segment concentrates on high-efficiency photovoltaic materials and manufacturing processes originally developed in partnership with academic and federal laboratories. By licensing proprietary cell architectures and overseeing pilot-scale production, Astrotech aims to reduce costs and accelerate adoption of clean-energy solutions in global markets.

Founded in 1984 as AIT International, Astrotech has evolved via strategic acquisitions and spin-offs to maintain a diversified technology portfolio. The company collaborates with public-sector agencies, research institutions and industry partners to advance its product pipeline. Astrotech’s leadership brings expertise in engineering, regulatory affairs and business development to guide the firm’s long-term growth and commercialization efforts.

View Astrotech Profile